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Regulatory oversight of the iron trade:
Posttranscriptional regulation in yeast
Though a required element, iron is toxic in high concentration. New evidence reveals pathways for controlling the abun-
dance of mRNAs encoded by iron utilization and distribution genes. These studies demonstrate sophisticated systems
that limit iron uptake under conditions of abundance and lead to metabolic remodeling when iron is limited.Iron metabolism follows the rules of eco- r
nomics, in that cells prioritize its alloca- g
ltion under conditions of scarcity. Three
factors are incorporated in the logic of g
ocellular metabolic regulation by iron.
First, while iron is environmentally plenti- m
Cful in the insoluble Fe3+ form, making it
bioavailable requires a significant energy C
tcost. Second, due to the facility with
which iron can be induced to lose or t
gain electrons, this cost is worth paying
for cells, making iron a common enzy- b
imatic cofactor for redox reactions. Third,
iron’s high affinity for oxygen renders it a
tuseful for oxygen-based enzymatic re-
actions and oxygen sensing, usually in t
tthe form of heme. This limited and essen-
tial resource requires strict oversight, r
psince the very property of oxygen affinity
that makes iron useful for enzymatic l4eactions also allows it to react with oxy- t
Ien-containing compounds and cata-
yze the formation of cell-damaging oxy- b
ten radicals. Thus, regulatory oversight
f cellular iron usage encompasses nu- d
terous pathways; two new studies in
ell (Puig et al., 2005) and Molecular i
eell (Lee et al., 2005) illustrate an impor-
ant molecular regulatory mechanism in d
dhis process.
Over the past decade, studies in the E
sudding yeast Saccharomyces cerevis-
ae have brought to light the mechanism m
Mnd regulation of iron transport across
he plasma membrane. High-affinity iron l
iransport systems exist for both elemen-
al and siderophore bound iron and are A
degulated transcriptionally as well as
osttranslationally. Transcriptional regu- h
tation in S. cerevisiae is effected by theranscription factor Aft1p (Yamaguchi-
wai et al., 2002) and to a lesser extent
y its paralogue Aft2p. Under iron limita-
ion, Aft1p/Aft2p induce several genes
irectly required for high-affinity iron
ransport and reduction. Additionally, many
ron-requiring enzymes are replaced by
nzymes (or metabolic pathways) that
o not utilize iron. This was elegantly
emonstrated in a study by Shakoury-
lizeh et al. (2004), who implicated tran-
criptional activation as part of the
echanism of metabolic remodeling.
ore recently, posttranscriptional regu-
ation has been shown to play a role in
ron-based metabolic remodeling. Aft1p/
ft2p, under iron-limiting conditions, in-
uce several genes directly required for
igh-affinity iron transport and reduc-
ion. The Aft1p target gene initiallyCELL METABOLISM : JULY 2005
P R E V I E Wtermed TIS11 but renamed CTH2 had (
been of unknown function, but Puig et F
al. (2005) demonstrate that CTH2 regu- e
lates a wide variety of genes that en- n
code proteins involved in iron- and oxy- R
gen-based metabolism. Cth2p binds to t
specific elements in the 3# UTR of i
mRNAs, causing a decrease in their half- S
life. Thus, under low iron conditions, i
mRNAs that increase iron storage or are s
high-end iron consumers are reduced in R
abundance. The result is that pathways i
that are parsimonious in iron usage are
dramatically upregulated in preference l
to those that use iron. While Cth2p has o
been shown to specifically bind its tar- 2
get mRNAs, its exact mechanism of ac- p
tion remains to be determined. Guided c
by studies in mammalian systems, Puig s
et al., noted that Cth2p contains a tan- i
dem zinc finger (TZF) motif, a domain s
that typifies the tristetraprolin (TTP) fam- d
ily of RNA binding proteins. In the mam- v
malian proteins TTP and BRF-1, this do- s
main binds AU-rich elements present in o
rapidly degraded mRNAs. Puig et al. p
tshowed that Cth2p binds similar ele-
ments in its targets and that these ele- q
mments are required for Cth2p-dependent
destabilization. Domains outside the TZF w
adomain in TTP and BRF-1 interact with
mRNA decapping, deadenylation, and e
texonucleolytic activities, thereby recruit-
ing these activities to target mRNAs ss
s
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Figure 1. Conceptual diagram of transcriptional and posttranscriptional regulation by iron in Saccharomyces
cerevisiae
iIron inhibits nuclear localization of Aft1p and Aft2p. Upon iron limitation, Aft1p and Aft2p translocate to the
dnucleus and activate target genes. One of these targets, CTH2 encodes a factor that promotes degradation
of genes normally utilized under iron-replete conditions. Rnt1p appears to downregulate a subset of low iron i
genes under iron-replete conditions. Hypothetical or speculative interactions are shown using dashed lines.
rnt1 cells are slow to induce Aft1p/Aft2p targets under iron-limiting conditions, suggesting Rnt1p has positive
mrole in Aft1p/2p activation. Additionally, Lee et al. (2005) noted that CTH2 mRNA appears upregulated in rnt1
lcells, raising the possibility of crosstalk between the two pathways.
i
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cCELL METABOLISM : JULY 2005eLykke-Andersen and Wagner, 2005).
aurther complexity in the TTP/AU-rich
tlement-mediated mRNA decay mecha-
tism has been uncovered, as micro-
ANAs (miRNAs) and RNA-mediated in-
lerference (RNAi) appear to be required
rn higher eukaryotes (Jing et al., 2005).
mince the RNAi machinery is not present
in S. cerevisiae, it will be of interest to
Ree if Cth2p has direct interactions with
cNA processing activities and if these
pnteractions are sufficient for mRNA decay.
tIn addition to posttranscriptional regu-
oation of metabolic pathways in the face
tf low iron, a recent study (Lee et al.,
t005) has described a complementary
rathway in which posttranscriptional pro-
besses appear to downregulate tran-
tcripts that encode proteins required for
ron transport. S. cerevisiae contains a
tingle RNase III homolog, Rnt1p, a
eouble-stranded RNA endonuclease in-
tolved in processing and surveillance of
Several noncoding RNAs. In examination
tf microarray data from rnt1 cells com-
pared to wild-type, Lee et al. determined
hat several mRNAs, including genes re- a
iuired for iron acquisition that are nor-
ally repressed in iron-replete media, a
gere upregulated in rnt1 cells (Lee et
l., 2005). Additionally, follow-up North- c
lrn blot analysis demonstrated the exis-
ence of aberrantly sized transcripts of s
mome identified mRNAs. These aberrantpecies were also affected in rrp6, a
train in which the function of the nuclear
xosome (the 3# > 5# RNA degradation
achinery) is abrogated; similar species
ere observed upon deletion or muta-
ion of XRN1 and RAT1, genes encoding
# > 3# RNA exonucleases. Lee et al.
ropose a model in which Rnt1p
revents expression of iron-starvation-
nduced mRNAs under iron-replete con-
itions by directly cleaving target mRNAs;
hese targets are subsequently degraded
y both 5# > 3# and 3# > 5# degradation
achinery. In vivo support for Rnt1p
unction in suppression of iron-induced
enes comes from the observation that
he rnt1 strain is sensitive to high iron
evels, as if these cells are sensitized to
ron toxicity by their reduced ability to
ownregulate iron transporters and the
ron reduction machinery.
The phenotype of rnt1 cells still re-
ains to be understood at the molecular
evel. The upregulation of low-iron genes
n rnt1 cells is relatively modest, and it
ould be interesting to know if rnt1
ells showed greater effects on protein
xpression of Rnt1p’s targets. Rnt1p’s
ction is nuclear, and it is conceivable
hat Rnt1p could alter mRNA export and
hus translation of its target mRNAs.
lso, paradoxical to the upregulation of
ow iron genes in iron-replete medium,
nt1 cells have a large delay in Aft1p-
ediated activation of these same low
ron genes in iron-limiting conditions.
ecent work has suggested that rat1-1
ells (Kim et al., 2004) and rrp6 cells
roduce a greater spectrum of aberrant
ranscripts owing to the respective roles
f the affected genes in transcription
ermination and surveillance of cryptic
ranscripts (Wyers et al., 2005). Thus,
egulation of iron-acquisition genes might
e part of a larger system of cryptic
ranscript control.
While the details are still forthcoming,
he studies by Puig et al. (2005) and Lee
t al. (2005) demonstrate posttranscrip-
ional regulation of iron-related genes in
. cerevisiae. Transcriptional and post-
ranscriptional regulation results in a so-
histicated multilevel regulation of iron
cquisition and use (Figure 1). Interest-
ngly, some of the first demonstrated ex-
mples of posttranscriptional control of
ene expression were iron-dependent
ontrol of ferritin and transferrin receptor
evels in mammalian cells. The yeast
tudies, in concert with the older mam-
alian work, demonstrate that regula-5
P R E V I E WStion of iron metabolism in eukaryotes is
multifaceted and involves transcriptional,
Jposttranscriptional, and posttranslational y
mechanisms. G
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